However, this is the first time a ratio between a supposed protective protein (cubilin) and a cancer aggressiveness promoter (MPO) measured in the urine of patients has been studied as a prognostic risk factor to predict recurrence and progression to muscle-invasive T1 bladder tumours. Here, CUBN is linked to cancer.